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SUMMARY.-Biopsies from 40 human tumours, obtained at operation, have
been transplanted to mice treated with antilymphocyte serum (ALS); viable
grafts were obtained from 6 tumours. A further 26 human tumours were
transplanted to mice thymectomized as adults and treated with ALS; viable
grafts were obtained in 6 cases.
THERE are numerous reports ofin vivo studies on human tumours transplanted
to laboratory animals, in which the immune response has been partially suppressed
by cortisone and irradiation (Toolan, 1955; Moore and Koike, 1964; Smith, 1969).
However, only a small percentage of biopsies of human tumours obtained at
operation can be maintained in this way, and even fewer can be induced to
proliferate. An immunosuppressant which would induce a higher percentage of
transplanted human tumours to proliferate would therefore be an advantage.
Antilymphocyte serum (ALS) has been shown to be an effective immuno-
suppressant (James, 1967), and we have previously demonstrated that human
tumour cell lines HeLa, Hep2 and Hsl will proliferate readily when transplanted
subcutaneously to mice treated with ALS (Phillips and Gazet, 1968). It was
consequently felt that ALS might prove of value in the transplantation of human
tumour biopsies.
METHODS
Anirnals
Newly weaned Swiss mice of either sex were used. The mice were maintained
as a closed colony.
Imrnmunosuppression
ALS was prepared in rabbits as previously described (Phillips and Gazet, 1967).
Individual sera were tested by their ability to sustain the growth of the human
tumour cell line HeLa in Swiss mice. Sera of adequate potency were pooled and
stored at -20° C. The mice were injected subcutaneously in the nape of the
neck with 05 ml. of ALS at the time of transplantation, and with 025 ml. of
ALS on alternate days thereafter.
Thymectomy appears to enhance the action of ALS (Jeejeebhoy, 1967;
Phillips and Gazet, 1968), therefore in some cases tumours were transplanted to
thymectomized mice treated with ALS. The mice were thymectomized using the
method described by Sjodin et al. (1963). Thymectomy was performed on 14-day-
old animals since in our hands thymectomy at this age resulted in fewer mortalities
due to technique than thymectomy of fully mature animals.ANTILYMPHOCYTE SERUM AND TUMOUR TRANSPLANTATION 93
Tugnour preparation
All tumours were transplanted within an hour after removal from the patient.
An apparently viable, uninfected portion of the tumour was excised from each
biopsy with sterile instruments, and minced with scissors to a fine brei in an equal
volume of Eagle's minimum essential tissue culture medium. Five mice were
then injected subcutaneously in the ventral midline with approximately 0*5 ml.
of the tumour brei, by means of a Bashford syringe fitted with a size 15 needle
(S.W.G.).
Animals were killed at intervals from day 10 to 30, and the site ofimplantation
excised, fixed in formalin, and examined histologically.
RESULTS
Transplantation to mice treated with ALS alone
Biopsies of 40 human tumours were transplanted to mice treated with ALS
alone. In the majority of cases, subcutaneous nodules formed at the site of
implantation, but oni histological examination viable groups of tumour cells were
evident in the case of only 6 tumours (Table I). In no cases did a tumour grow
in all 5 mice transplanted. Viable tumour cells were evident for up to 21 days
(Table II).
TABLE I. Tumours Transplanted to Mice Treated with ALS
Number
Tumour type Nuimber positive
Anus . . 1 0
Basal cell . . 1 0
Breast 4 . 0
Bladder 3 0
ColoI 10 3
Lung 2 . 0
Ovary 2 0
Parotid 1 0
Rectum 9 0
Sarcoma . 1 0
Stomach 5 2
Metastatic deposit origin unknown 1 1
Total . 40 6
TABLE II. Positive Transplants8-Mice Treated with ALS Alone
Days on
Number of mice which
Tumour type in which p)ositive positive
Colon (a) 2. 10, 14
Colon (b) 3 . 10, 15, 21
Colon (c) 1 10
Stomach (a) 2 10, 15
Stomach (b) 1 10
Mletastatic deposit 2 10, 16
As sufficient material was available, one of the carcinomata of the colon (a)
was transplanted intraperitoneally as well as subcutaneously, and in this case
growth was obtained at both sites. The tumour transplanted intraperitoneally
grew as small nodules attached to the mesentery. Histological sections of the
transplant were stained with Southgate stain which demonstrated the presence
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of mucin. A carcinoma of the colon (b) which proved positive in 3 mice, had
become organized into acini by day 12 (Fig. 1).
Transplantation to mice treated with thymectomy and ALS
Biopsies of a further 26 human tumours were transplanted to mice treated
with thymectomy and ALS, viable transplants were obtained with 6 tumours
(Tables III and IV).
TABLE III.-Tumours transplanted to Mice Treated with ALS and Thymectomy
Number
Tumour type Number postive
Breast . . . . 6 . 1
Colon . . . . . 4 . 1
Lung . . . . 1 0
Pancreas . . . . 1 0
Parotid . . . . 1 . 0
Rectum . . . . 6 . 2
Seminoma . . . 1 . 0
Stomach . . . . 5 . 2
Metastatic deposit origin unknown . 1 . 0
Total . . . . . . 26 . 6
TABLE IV.-Positive Transplants-Mice Treated with Thymectomy and ALS
(These tumours do not correspond to those in Table II)
Days on
Number of mice which
Tumour type in which positive positive
Breast . . . 2 . 10, 21
Colon . . . 1 . 10
Rectum (a) . . 1 . 25
Rectum (b) . 2 . 10, 14
Stomach (a) . 3 . 9, 15, 23
Stomach (b) . . 1 . 10
Two transplants from the biopsy of a breast carcinoma proved positive in
female mice, but no viable tumour cells were evident in the remaining 3 male mice.
Both the carcinoma of the colon and the rectum (a) were organized into acini
(Figs. 2 and 3). Histological sections of the carcinomata ofthe colon, rectum (a)
and stomach were positive when stained with Southgate stain for mucin.
DISCUSSION
The percentage of tumours maintained in mice treated with ALS, or ALS
combined with thymectomy reported here is scarcely higher than that reported
with other methods of immunosuppression. However, there are two possible
EXPLANATION OF PLATES
FIG. 1.- Carcinoma of the colon in mouse treated with ALS, day 12. H. and E.
Fie. 2.-Carcinoma ofthe colon in mouse treated with thymectomy and ALS, day 10. H. and
E.
FIG. 3.-Carcinoma of the rectum in mouse treated with thymectomy and ALS, day 14.
H. and E.
FIG. 4.-Carcinoma of the stomach in mouse treated with thymectomy and ALS, day 23.
H. and E.
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reasons for this. Firstly, tumours were selected by macroscopic examination
only. Ideally the most viable, stroma free portion of the biopsy should have
been selected microscopically for transplantation. Secondly, a high proportion
of the biopsies were from carcinomata of the breast and bowel, both these types
of tumour have been reported as particularly difficult to transplant. We have
previously transplanted a similar series of 40 biopsies of human tumour to mice
treated with cortisone, and were able to obtain viable grafts in only 3 cases
(unpublished results). In our hands at least therefore, ALS, particularly if
combined with thymectomy, appears to induce a higher percentage of trans-
planted human tumours to proliferate than cortisone.
ALS has the additional advantages of being simple to administer, and of low
toxicity. None of the animal hosts died as a result of immunosuppressive
treatment, although ALS was administered for up to 30 days.
We should like to thank Mr. Paul L. Manning, A.I.M.L.T., for the histological
work.
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